Top Story

Celiac symposium features latest in emerging therapeutics, gluten monitoring

Celiac symposium features latest in emerging therapeutics, gluten monitoring
October 10, 2017

In this guest commentary, Jocelyn Silvester, MD, PhD, director of research for the Celiac Disease Program at Boston Children’s Hospital, recaps some of the most impactful research presented at the International Celiac Disease Symposium held last month in New Delhi, India.

The 17th International Celiac Disease Symposium in New Delhi focused attention on celiac disease in an area of high prevalence, yet relatively low awareness. Globally, the seroprevalence of celiac disease associated antibodies is 1.4% and the prevalence of celiac disease is estimated to be 0.7% (0.8% in Asia). The prevalence is higher in children, which suggests that the population prevalence of celiac disease will continue to increase.

In the Journals Plus

Fracture risk increases with type 1 diabetes, celiac disease

October 5, 2017
Young adults with type 1 diabetes and celiac disease are more likely to sustain fractures than those who have type 1 diabetes alone, according to findings reported in…

Celiac disease: What PCPs need to know

September 13, 2017
September 13 is designated as National Celiac Disease Awareness Day with the intention of raising awareness for and education of the disease, which affects approximately…

Gluten-free diets: In celiac disease absence, a source of confusion, uncertainty

September 12, 2017
The phrase “gluten-free” has become ubiquitous in American diet culture, and is a fixture in grocery store aisles, cookbooks and restaurant menus. Regardless…
More Headlines »